Taiwan's Academia Sinica said Friday that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to the development of targeted drugs to stop the virus from replicating itself in patients' bodies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Zeiss to expand in Taiwan, announce AI investment in May
04/30/2025 04:39 PM - Business
U.S. dollar closes sharply lower on Taipei forex market
04/30/2025 04:25 PM - Politics
Canadian think tank urges Ottawa to unambiguously support Taiwan
04/30/2025 04:14 PM - Business
Manufacturing sector weakens sharply amid Trump tariff threat
04/30/2025 01:33 PM - Business
U.S. commerce secretary visits TSMC Arizona for 3rd fab groundbreaking
04/30/2025 01:01 PM